A detailed history of Hm Payson & CO transactions in Mckesson Corp stock. As of the latest transaction made, Hm Payson & CO holds 4,134 shares of MCK stock, worth $2.17 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,134
Previous 4,285 3.52%
Holding current value
$2.17 Million
Previous $2.5 Million 18.35%
% of portfolio
0.04%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$479.06 - $630.38 $72,338 - $95,187
-151 Reduced 3.52%
4,134 $2.04 Million
Q2 2024

Aug 13, 2024

SELL
$518.81 - $607.81 $254,216 - $297,826
-490 Reduced 10.26%
4,285 $2.5 Million
Q1 2024

Jun 20, 2024

SELL
$473.42 - $539.26 $104,625 - $119,176
-221 Reduced 4.42%
4,775 $2.56 Million
Q4 2023

Feb 13, 2024

SELL
$437.42 - $470.64 $284,323 - $305,916
-650 Reduced 11.51%
4,996 $2.31 Million
Q3 2023

Nov 06, 2023

BUY
$402.4 - $446.42 $57,945 - $64,284
144 Added 2.62%
5,646 $2.46 Million
Q2 2023

Jul 17, 2023

BUY
$354.01 - $427.31 $1.44 Million - $1.74 Million
4,062 Added 282.08%
5,502 $2.35 Million
Q4 2022

Feb 06, 2023

BUY
$346.68 - $397.58 $3,813 - $4,373
11 Added 0.77%
1,440 $540,000
Q2 2022

Aug 15, 2022

SELL
$300.57 - $336.42 $2,103 - $2,354
-7 Reduced 0.49%
1,429 $466,000
Q1 2022

May 12, 2022

BUY
$244.61 - $310.48 $1,712 - $2,173
7 Added 0.49%
1,436 $440,000
Q4 2021

Feb 15, 2022

BUY
$198.21 - $248.9 $116,943 - $146,851
590 Added 70.32%
1,429 $355,000
Q4 2020

Mar 10, 2021

SELL
$143.79 - $183.66 $7,764 - $9,917
-54 Reduced 6.05%
839 $146,000
Q2 2020

Aug 13, 2020

SELL
$125.49 - $164.68 $28,611 - $37,547
-228 Reduced 20.34%
893 $137,000
Q1 2020

Jul 01, 2020

BUY
$115.75 - $170.96 $17,709 - $26,156
153 Added 15.81%
1,121 $152,000
Q2 2019

Aug 15, 2019

BUY
$112.47 - $134.93 $108,870 - $130,612
968 New
968 $130,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Hm Payson & CO Portfolio

Follow Hm Payson & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.